Objective to discuss the correlation between the prognosis of pulmonary surfactant protein A (SP-A) and community-acquired pneumonia (CAP). Methods 100 CAP patients, from August 2013 to September 2014, were selected randomly. According CURB-65 evaluative criteria, patients were divided into mild group, moderate group and severe group respectively; In accordance with the criteria of CAP critical rating 7, patients were divided into low, intermediate, high and extremely high risk groups. The differences on the clinical prognostic indicators (hospital stays, mechanical ventilation and oxygenation index) through comparisons among groups. Results SP-A content and oxygenation index for patients between moderate and severe groups were significantly less than those in mild group (P < 0.05), while the hospital stays and mechanical ventilation were distinctly larger than those in mild group (P < 0.05). The SP-A content and oxygenation index of patients among intermediate, high and extremely high risk groups were significantly less than those in low-risk group (P < 0.05), while the hospital stays and mechanical ventilation were remarkably larger than those in low-risk group (P < 0.05). Conclusion SP-A, a sensitive and accurate biological specific indicator, shows a crucial evaluation value on the disease severity and prognosis of CAP.

1.
Chalmers
JD
,
Rutherford
J.
Can we use severity assessment tools to increase outpatient management of community-acquired pneumonia? [J]
.
Eur J Intern Med.
2012
;
23
(
5
):
398
406
.
2.
Polverino
E
,
Torres Marti
A.
Community-acquired pneumonia [J]
.
Minerva Anestesiol.
2011
;
77
(
2
):
196
211
.
3.
Atochina
EN
,
Beck
JM
,
Scanlon
ST
,
Prreston
AM
,
Beers
MF
.
Pneumocystis carinii pneumonia alters expression and distribution of lung collectins SP-A and SP-D [J]
.
J Lab Clin Med.
2001
;
137
(
6
):
429
439
.
4.
Fernandez-Real
JM
,
Chico
B
,
Shiratori
M
,
Nara
Y
,
Takahashi
H
,
Ricart
W.
Circulating surfactant protein A (SP-A), a marker of lung injury, is associated with insulin resistance [J]
.
Diabetes Care.
2008
;
31
(
5
):
958
963
.
5.
Mandell
LA
,
Wunderink
RG
,
Anzurto
A
, et al 
Infectious Diseases Society of America/ American Thoracic Society consensus guidelines on the management of community acquired pneumonia in adults [J]
.
Clin Infect Dis.
2007
;
44
(
S2
):
27
72
.
6.
Haque
R
,
Umstead
TM
,
Ponnuru
P
, et al 
Role of surfactant protein-A (SP-A) in lung injury in response to acute ozone exposure of SP-A deficient mice [J]
.
Toxicol Appl Pharmacol.
2007
;
220
(
1
):
72
82
.
7.
Jing
JH
,
Li
LY
.
Study on the changes in serum and copeptin levels among patients with community-acquired pneumonia and their correlations to procalcitonin and C-reactive protein [J]
.
J Practi Med.
2014
;
30
(
12
):
2010
2011
.
8.
Guo
Q
,
Li
H Y
,
Zhou
Y P
, et al 
Weight of the CURB-65 Criteria for Community-Acquired Pneumonia in a Very Low-Mortality-Rate Setting [J]
.
Intern Med.
2012
;
51
(
18
):
2521
2527
.
9.
Richards
G
,
Levy
H
,
Laterre
P F
, et al 
CURB-65, PSI, and APACHE II to assess mortality risk in patients with severe sepsis and community acquired pneumonia in PROWESS [J]
.
J Intensive Care Med.
2011
;
26
(
1
):
34
40
.
10.
Ronan
D
,
Nathwani
D
,
Davey
P
,
Barlow
G.
Predicting mortality in patients with community-acquired pneumonia and low CURB-65 scores [J]
.
Eur J Clin Microbiol Infect Dis.
2010
;
29
(
9
):
1117
1124
.
11.
Torralba
MA
,
Amores-Arriaga
B
,
Olivera
S
,
Perez-Calvo
JI
.
Validity of Fine and CURB scales in the treatment of community-acquired pneumonia in adults [J]
.
Med Clin (Barc)
.
2010
;
135
(
13
):
624
625
.
12.
Welte
T.
Risk factors and severity scores in hospitalized patients with community-acquired pneumonia: prediction of severity and mortality [J]
.
Eur J Clin Microbiol Infect Dis.
2012
;
31
(
1
):
33
47
.
This content is only available via PDF.